CM
GSK icon

Crestline Management’s GSK GSK Stock Holding History

Crestline Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,970
Closed -$1.05M – 269
2024
Q4 		$1.05M Buy
+30,970
New +$1.11M 0.03% 405
2021
Q3 		– Sell
-53,081
Closed -$2.64M – 246
2021
Q2 		$2.64M Buy
+53,081
New +$2.55M 0.23% 67

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crestline Management's GSK Position: Q1 2025 in Review

Crestline Management sold out of GSK (GSK) in Q1 2025, closing a stake of 30,970 shares — an estimated $1.05M sold.

Crestline Management first reported a position in GSK in Q2 2021 and held it in 2 quarters. The position peaked at $2.64M in Q2 2021. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Crestline Management reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 30,970 GSK shares in Q1 2025, an estimated $1.05M.
  • Crestline Management first reported a position in GSK in Q2 2021 and held it in 2 quarters.
  • Crestline Management's GSK position peaked at $2.64M in Q2 2021.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.